BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19838217)

  • 21. TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.
    Liu X; Wang C; Gu Y; Zhang Z; Zheng G; He Z
    Mol Cell Biochem; 2015 Jan; 398(1-2):175-83. PubMed ID: 25260657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.
    Wang S; Zhang H; Scharadin TM; Zimmermann M; Hu B; Pan AW; Vinall R; Lin TY; Cimino G; Chain P; Vuyisich M; Gleasner C; Mcmurry K; Malfatti M; Turteltaub K; de Vere White R; Pan CX; Henderson PT
    PLoS One; 2016; 11(1):e0146256. PubMed ID: 26799320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian DNA beta-polymerase in base excision repair of alkylation damage.
    Sobol RW; Wilson SH
    Prog Nucleic Acid Res Mol Biol; 2001; 68():57-74. PubMed ID: 11554313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER.
    Wang M; Li E; Lin L; Kumar AK; Pan F; He L; Zhang J; Hu Z; Guo Z
    Mol Cancer Res; 2019 Oct; 17(10):2077-2088. PubMed ID: 31350308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA polymerase β: A missing link of the base excision repair machinery in mammalian mitochondria.
    Prasad R; Çağlayan M; Dai DP; Nadalutti CA; Zhao ML; Gassman NR; Janoshazi AK; Stefanick DF; Horton JK; Krasich R; Longley MJ; Copeland WC; Griffith JD; Wilson SH
    DNA Repair (Amst); 2017 Dec; 60():77-88. PubMed ID: 29100041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA polymerase lambda protects mouse fibroblasts against oxidative DNA damage and is recruited to sites of DNA damage/repair.
    Braithwaite EK; Kedar PS; Lan L; Polosina YY; Asagoshi K; Poltoratsky VP; Horton JK; Miller H; Teebor GW; Yasui A; Wilson SH
    J Biol Chem; 2005 Sep; 280(36):31641-7. PubMed ID: 16002405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage.
    Ochs K; Sobol RW; Wilson SH; Kaina B
    Cancer Res; 1999 Apr; 59(7):1544-51. PubMed ID: 10197627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymerase beta promotes recruitment of DNA ligase III alpha-XRCC1 to sites of base excision repair.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    Biochemistry; 2005 Aug; 44(31):10613-9. PubMed ID: 16060670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses.
    Sobol RW; Kartalou M; Almeida KH; Joyce DF; Engelward BP; Horton JK; Prasad R; Samson LD; Wilson SH
    J Biol Chem; 2003 Oct; 278(41):39951-9. PubMed ID: 12882965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
    Jaiswal AS; Banerjee S; Aneja R; Sarkar FH; Ostrov DA; Narayan S
    PLoS One; 2011 Feb; 6(2):e16691. PubMed ID: 21311763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens.
    Cabelof DC; Guo Z; Raffoul JJ; Sobol RW; Wilson SH; Richardson A; Heydari AR
    Cancer Res; 2003 Sep; 63(18):5799-807. PubMed ID: 14522902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines.
    Bhattacharyya N; Chen HC; Wang L; Banerjee S
    Gene Expr; 2002; 10(3):115-23. PubMed ID: 12064574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo.
    Guichard S; Arnould S; Hennebelle I; Bugat R; Canal P
    Anticancer Drugs; 2001 Oct; 12(9):741-51. PubMed ID: 11593056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA polymerase lambda mediates a back-up base excision repair activity in extracts of mouse embryonic fibroblasts.
    Braithwaite EK; Prasad R; Shock DD; Hou EW; Beard WA; Wilson SH
    J Biol Chem; 2005 May; 280(18):18469-75. PubMed ID: 15749700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon cancer-associated DNA polymerase β variant induces genomic instability and cellular transformation.
    Nemec AA; Donigan KA; Murphy DL; Jaeger J; Sweasy JB
    J Biol Chem; 2012 Jul; 287(28):23840-9. PubMed ID: 22573322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS.
    Saintas E; Abrahams L; Ahmad GT; Ajakaiye AM; AlHumaidi AS; Ashmore-Harris C; Clark I; Dura UK; Fixmer CN; Ike-Morris C; Mato Prado M; Mccullough D; Mishra S; Schöler KM; Timur H; Williamson MD; Alatsatianos M; Bahsoun B; Blackburn E; Hogwood CE; Lithgow PE; Rowe M; Yiangou L; Rothweiler F; Cinatl J; Zehner R; Baines AJ; Garrett MD; Gourlay CW; Griffin DK; Gullick WJ; Hargreaves E; Howard MJ; Lloyd DR; Rossman JS; Smales CM; Tsaousis AD; von der Haar T; Wass MN; Michaelis M
    PLoS One; 2017; 12(2):e0172140. PubMed ID: 28192521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor.
    Takahashi M; Koi M; Balaguer F; Boland CR; Goel A
    J Biol Chem; 2011 Apr; 286(14):12157-65. PubMed ID: 21285347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of DNA polymerase beta-dependent base excision repair in response to oxidative stress in vivo.
    Cabelof DC; Raffoul JJ; Yanamadala S; Guo Z; Heydari AR
    Carcinogenesis; 2002 Sep; 23(9):1419-25. PubMed ID: 12189182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.